Glucagon-like peptide 1 and type 1 diabetes: NOD ready for prime time?

Glucagon-like peptide 1 and type 1 diabetes: NOD ready for prime time? Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Glucagon-like peptide 1 and type 1 diabetes: NOD ready for prime time? Abstract Text:

Nicole A Sherry,Wei Chen,Jake A Kushner,Mariela Glandt,Qizhi Tang,Sue Tsai,Pere Santamaria,Jeffrey A Bluestone,Anne-Marie B Brillantes,Kevan C Herold,

Glucagon-like peptide 1 and type 1 diabetes: NOD ready for prime time? Publishing Authors By Initials

NA Sherry,W Chen,JA Kushner,M Glandt,Q Tang,S Tsai,P Santamaria,JA Bluestone,AM Brillantes,KC Herold,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Glucagon-like peptide 1 and type 1 diabetes: NOD ready for prime time? Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Endocrinology

VOLUME: 148

Page Numbers: 5133-5

Journal Abbreviation: Endocrinology

ISSN: 0013-7227

DAY: 27

MONTH: Nov

YEAR: 2007

Glucagon-like peptide 1 and type 1 diabetes: NOD ready for prime time? Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 375040

Glucagon-like peptide 1 and type 1 diabetes: NOD ready for prime time? Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Glucagon-like peptide 1 and type 1 diabetes: NOD ready for prime time? Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Glucagon-like peptide 1 and type 1 diabetes: NOD ready for prime time?

AFFILIATION: Department of Medicine, Samuel Lunenfeld Research Institute, Mt Sinai Hospital, SLRI 975C, Toronto, Ontario, Canada.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Endocrinology

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Glucagon-like peptide 1 and type 1 diabetes: NOD ready for prime time? Related Publications

• A paradoxical peace: HIV in post-conflict states.
• A rapid bioassay in rats for panthenol.
• Acquired perforating dermatosis. Evidence for combined transepidermal elimination of both collagen and elastic fibers.
• An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose homeostasis.
• Antimicrobial activity of varying concentrations of sodium hypochlorite on the endodontic microorganisms Actinomyces israelii, A. naeslundii, Candida albicans and Enterococcus faecalis.
• Associations of endodontic symptoms and signs with particular combinations of specific bacteria.
• Beta-cell replication by loosening the brakes of glucagon-like peptide-1 receptor signaling.
• Bringing Health Care Advocacy to a Public Defender's Office.
• Clinical decisions. Management of type 2 diabetes.
• Cyclic or rhythmic oculomotor paralysis; case report.
• Differential Antidiabetic Efficacy of Incretin Agonists Versus DPP-4 Inhibition in High Fat Fed Mice.
• Exendin-4 modulates diabetes onset in nonobese diabetic mice.
• Glucagon-like peptide 1 and type 1 diabetes: NOD ready for prime time?
• Glucagon-like peptide-2 does not modify the growth or survival of murine or human intestinal tumor cells.
• Incretin receptors for glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide are essential for the sustained metabolic actions of vildagliptin in mice.
• Insulin action in the double incretin receptor knockout mouse.
• Intensive insulin therapy in newly diagnosed type 2 diabetes.
• On drug treatment and social control: Russian narcology's great leap backwards.
• Phosphorescence excitation spectrum of the T(1)(n,pi(*))<--S(0) transition of 4H-pyran-4-one.
• Return to galileo? The inquisition of the international narcotic control board.
• Tobacco harm reduction: how rational public policy could transform a pandemic.
• Variations in the susceptibilities of components of the endodontic microflora to biomechanical procedures.
• [Home technological support network for technology-dependent children discharged from a state-run hospital.]
• [Not Available.]